Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) EPS (Basic) (2019 - 2025)

Pulmonx (LUNG) has disclosed EPS (Basic) for 7 consecutive years, with -$0.34 as the latest value for Q3 2025.

  • Quarterly EPS (Basic) rose 5.56% to -$0.34 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.41 through Sep 2025, up 4.08% year-over-year, with the annual reading at -$1.44 for FY2024, 10.0% up from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.34 at Pulmonx, up from -$0.38 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.28 in Q3 2021, with the low at -$0.43 in Q1 2022.
  • Average EPS (Basic) over 5 years is -$0.37, with a median of -$0.36 recorded in 2021.
  • Peak annual rise in EPS (Basic) hit 94.15% in 2021, while the deepest fall reached 105.02% in 2021.
  • Over 5 years, EPS (Basic) stood at -$0.36 in 2021, then fell by 5.56% to -$0.38 in 2022, then increased by 5.26% to -$0.36 in 2023, then increased by 8.33% to -$0.33 in 2024, then decreased by 3.03% to -$0.34 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.34, -$0.38, and -$0.36 for Q3 2025, Q2 2025, and Q1 2025 respectively.